BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VTIMEZONE TZID:America/Denver X-LIC-LOCATION:America/Denver BEGIN:DAYLIGHT TZOFFSETFROM:-0700 TZOFFSETTO:-0600 TZNAME:MDT DTSTART:19700308T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0600 TZOFFSETTO:-0700 TZNAME:MST DTSTART:19701101T020000 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT UID:cd79b313221b1f3da777aff1c1078782392 CATEGORIES:Webinar SUMMARY:Webinar: Getting to Know the New JAKs on the Block: Pharmacy-Focused Insights for Atopic Dermatitis and Alopecia Areata DESCRIPTION:
Sept. 14, 2021 fro m 12 p.m. to 1 p.m.
Activity Description:
Led by a faculty team of specialty pharmacy and dermatology experts, this
curriculum will provide targeted education to community pharmacists for the
emerging therapies on the horizon in moderate-to-severe atopic dermatitis
(AD) and alopecia areata (AA). The presentation will provide discussion aro
und the connection between AD and AA, the role of Janus Kinase (JAK)-signal
transducer activator of transcription pathways in the pathogenesis of AD a
nd AA, the latest clinical trial data on emerging agents, racial and health
disparities in patients with AA and AD, and the unique role of the pharmac
ist in providing education and obtaining prior authorization to medications
. Utilizing video interviews with actual patients, you will gain greater aw
areness and empathy for the significant quality of life burden that patient
s who have these conditions encounter on a daily basis. This program has be
en thoughtfully crafted to be interactive and will include engaging discuss
ions, valuable teaching points, and ample opportunity for Q&A with lead
ing experts.
Learning Objectives:
Target Audience
This curriculum is intended for a broad audience of community pharmacists,
dermatologic specialty pharmacists, and managed care professionals involved
in the care and treatment of patients with AD and/or AA.
Spe
akers:
Amanuel Kehasse, PharmD
Course D
irector
Clinical Pharmacy Specialist
Clinical Pharmacy Specialist
in Autoimmune and Interstitial lung disease
Boston Medical Center Hea
lth System Boston, MA
Peter A Lio, MD
Assistant
Professor of Clinical Dermatology and Pediatrics
Northwestern Feinberg
School of Medicine Director, Chicago Integrative Eczema Center Founding Pa
rtner
Medical Dermatology Associates of Chicago Chicago, IL
A
CPE
The University of Rhode Island College of Pharmacy is acc
redited by the Accreditation Council for Pharmacy Education (ACPE) as a pro
vider of continuing pharmacy education. This is an application-based educat
ional activity. Pharmacists will receive 1.0 contact
hours (0.10 ceus)
for the educational activity. No partial credit is available. ACPE Univers
al Activity Number (UAN): 0060-9999-21-023-L01-P
ACCME
Boston University School of Medicine is accredited by the Accredita
tion Council for Continuing Medical Education to provide continuing medical
education for physicians.
Boston University School of Medicine design
ates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Phys
icians should claim only the credit commensurate with the extent of their p
articipation in the activity.
Acknowledgment
Th
is activity is presented by Boston University School of Medicine and The Un
iversity of Rhode Island College of Pharmacy and is supported by and indepe
ndent educational grant from Pfizer.